Trials / Completed
CompletedNCT00143507
The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction
Effects of Ivabradine on Cardiovascular Events in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction. A Three-year Randomised Double-blind Placebo-controlled International Multicentre Study.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 10,917 (actual)
- Sponsor
- Institut de Recherches Internationales Servier · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to test whether ivabradine is able to reduce cardiovascular events when given to patients with coronary artery disease and impaired heart function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ivabradine | |
| DRUG | Placebo |
Timeline
- Start date
- 2004-12-01
- Primary completion
- 2008-02-01
- Completion
- 2008-02-01
- First posted
- 2005-09-02
- Last updated
- 2018-04-12
- Results posted
- 2015-06-25
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00143507. Inclusion in this directory is not an endorsement.